Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Efficacy and Safety of a Proposed Omalizumab Biosimilar Compared to the Reference Product in the Management of Uncontrolled Moderate-To-Severe Allergic Asthma: A Multicenter, Phase Iii, Randomized, Double-Blind, Equivalency Clinical Trial
Morteza Samadi-Foroushani
Morteza Samadi-Foroushani

Professor of Medical Immunology

Department of Immunology, School of Medicine

Isfahan University of Medical Sciences

All Documents
12. Association Between Interleukin-23 Receptor R381q Gene Polymorphism and Asthma, Iranian Journal of Allergy, Asthma and Immunology (2015)